Living with Melanoma

Chapter 1: What Just Happened: Understanding Melanoma

You just heard the word melanoma from a doctor, maybe over the phone, maybe in an exam room while you were still half-dressed, and now you are holding a diagnosis you did not have yesterday. Before anything else, it helps to know exactly what that word means and what it does not mean, because "skin cancer" covers a lot of ground, and melanoma is a specific, less common corner of it with its own rules.

What melanoma actually is

Your skin holds a population of cells called melanocytes, scattered through the deepest layer of the epidermis, the outermost skin layer. Their job is to make melanin, the pigment that gives skin, hair, and eyes their color and offers some natural shielding from ultraviolet light. When you tan, you are watching melanocytes ramp up melanin production in response to UV exposure. Melanoma is what happens when a melanocyte's internal instructions get scrambled and it starts dividing without the normal stop signals, building a tumor out of what used to be an ordinary pigment cell.

Melanoma comes from pigment cells rather than the flatter skin cells that make up most of the epidermis, and that single fact is why it behaves differently from the two other cancers people lump together under "skin cancer": basal cell carcinoma and squamous cell carcinoma. Those two arise from keratinocytes, the workhorse cells that form the physical barrier of your skin. They are far more common than melanoma and, in the overwhelming majority of cases, they stay put. They grow slowly, locally, and rarely travel to other organs. Melanocytes are wired differently. They already have some built-in capacity to migrate, since during development they travel long distances through the embryo to reach the skin in the first place. A melanoma keeps a version of that migratory instinct, which is part of why it is more willing than basal or squamous cell cancer to break through the boundary between the epidermis and the deeper tissue and enter the bloodstream or lymphatic system. That capacity to spread, called metastasis, is the reason melanoma gets so much medical attention despite being a small slice of skin cancer cases overall.

The numbers, in context

Melanoma is estimated to account for roughly 97,610 new diagnoses a year in the United States, alongside about 7,990 deaths, based on figures from the National Cancer Institute's SEER program. Sit with the shape of those two numbers for a second: melanoma makes up only about 1% of all skin cancer diagnoses, yet it is responsible for the large majority of skin cancer deaths. Basal and squamous cell cancers are diagnosed millions of times a year combined, and most of those cases are handled with an office procedure and never come up again. Melanoma is diagnosed far less often, but because of its ability to metastasize, it carries most of the risk in that category. That is the entire logic behind why your dermatologist takes a changing mole so seriously, and why the workup for melanoma looks more involved than the workup for a basal cell spot on your nose.

There is a real reason for optimism buried in those same statistics. Survival in melanoma is heavily weighted toward how early the disease is caught. When melanoma is found while it is confined to the skin, without evidence it has reached lymph nodes or distant organs, surgical removal alone is frequently curative, and the five-year survival rate for that group of patients is very high. The picture changes as the disease reaches lymph nodes and changes further still if it reaches distant organs, which is exactly why the chapters ahead spend so much time on staging, biopsy, and the treatment toolbox available at each stage. If your diagnosis came early, and a large share do, the biology described above is working in your favor rather than against you.

Melanocytes and melanin, the short version

It is worth slowing down on the biology, because the rest of this book leans on it repeatedly. Picture the epidermis as a thin, layered wall. The bottom layer, called the basal layer, is where new skin cells are produced and where melanocytes live, embedded among the basal keratinocytes like scattered seed cells. Each melanocyte has thin, branching arms that reach out to dozens of neighboring keratinocytes, feeding them packets of melanin the way a utility line feeds power to individual houses. Those melanin packets absorb and scatter ultraviolet light before it can reach deeper into the skin, which is the biological reason melanin exists at all. Skin, hair, and eye color come from how much melanin a person's melanocytes produce and what type they produce, and the cells themselves are present in essentially everyone, regardless of skin tone.

When ultraviolet radiation damages the DNA inside a melanocyte, and the cell's repair systems fail to fix that damage correctly, the cell can pick up mutations that disable its normal growth controls. A melanocyte carrying the right combination of those mutations stops behaving like a quiet pigment factory and starts behaving like a tumor, first inside the basal layer, then potentially downward through the deeper skin and beyond. The next chapter goes further into the specific mutations involved. For now, the important image to carry is simply this: melanoma starts as one misbehaving cell in a population that every person's skin already contains, not as some foreign invader.

Melanoma versus basal and squamous cell skin cancer, at a glance

| | Melanoma | Basal cell carcinoma | Squamous cell carcinoma | |---|---|---|---| | Cell of origin | Melanocyte (pigment cell) | Basal keratinocyte | Squamous keratinocyte | | Share of skin cancer diagnoses | About 1% | Most common skin cancer overall | Second most common | | Typical growth pattern | Can grow outward along the surface first, then downward; some subtypes grow downward early | Slow, local, rarely spreads | Local, occasionally spreads if neglected | | Ability to metastasize | Meaningful risk if not caught early | Very low | Low, but higher than basal cell | | Share of skin cancer deaths | Large majority | Small | Small | | Usual first treatment | Surgical excision, sometimes with further staging | Surgical removal or localized treatment | Surgical removal or localized treatment |

Use this table as an orientation point, not a diagnostic tool. Your own pathology report, discussed in a later chapter, is what tells you which category and subtype you are actually dealing with.

Who gets it, and why age and sex matter here

One pattern in melanoma catches people off guard: before age 50, it shows up more often in women, and after 50, it shows up more often in men. Researchers do not point to a single tidy explanation for the switch. Contributing threads likely include differences in sun exposure patterns across a lifetime, such as tanning bed use, which has historically skewed toward younger women, and differences in how consistently men seek dermatology care as they age, which can affect how early a mole change gets flagged rather than how often melanoma actually starts. The practical takeaway is not that either sex is "safe" at any age: the population-level pattern shifts partway through adulthood, which is part of why dermatologists ask about age and sex alongside sun history when assessing risk.

The figure below

The diagram that follows shows a simplified cross-section of skin, with melanocytes marked in the basal layer where they normally sit, next to a small drawing of how melanoma tends to spread compared with basal and squamous cell cancer.

What this chapter leaves you with

Melanoma is a cancer of melanocytes, the pigment-making cells in the skin's basal layer, and it is distinguished from basal and squamous cell skin cancer chiefly by its greater ability to spread beyond the original spot. The numbers above show a disease that is rare among skin cancers but responsible for most of the deaths in that category. Before age 50 it appears more often in women; after 50 it appears more often in men. And when melanoma is caught while it is still confined to the skin, surgery alone cures it in the large majority of cases. The chapters ahead build directly on these four facts: the cell type involved, the scale of the disease, the age and sex pattern, and the outsized importance of catching it early.

End of free sample. The full book picks up right where this leaves off.